This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Navitor Pharmaceuticals, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Sarah Mahoney - Innovator in Rheb Inhibitors
Introduction
Sarah Mahoney is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target Rheb-mediated disorders. Her innovative work has led to the filing of one patent, showcasing her expertise and dedication to advancing medical science.
Latest Patents
Sarah Mahoney holds a patent for "Heteroaryl Rheb inhibitors and uses thereof." This invention provides compounds of general Formula I and I', along with compositions and methods for treating Rheb-mediated disorders. Her research focuses on creating effective treatments that can improve patient outcomes.
Career Highlights
Sarah is currently employed at Navitor Pharmaceuticals, Inc., where she continues to push the boundaries of pharmaceutical research. Her work at Navitor has positioned her as a key player in the development of innovative therapies.
Collaborations
Throughout her career, Sarah has collaborated with talented individuals such as Lisa Molz and Sridhar Narayan. These partnerships have enriched her research and contributed to the success of her projects.
Conclusion
In summary, Sarah Mahoney is an accomplished inventor whose work in Rheb inhibitors is paving the way for new treatments in medicine. Her contributions to the field are invaluable, and her ongoing research promises to make a significant impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile